A1 receptors mediate adenosine inhibitory effects in mouse ileum via activation of potassium channels

Life Sciences

Volumn 84, Issue 21-22, 2009, Pages 772-778

  Zizzo, Maria Grazia ^a   Bonomo, Alessandra ^b   Belluardo, Natale ^b   Mulè, Flavia ^a   Serio, Rosa ^a  

^a Dipartimento di Biologia Animale e dell'Uomo   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adenosine; Adenosine A1 receptors; Mechanical activity; Mouse ileum; P1 purinoceptors; Potassium channels

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 AMINO 4 (3 HYDROXYPHENYL) 6 (1H IMIDAZOL 2 YLMETHYLSULFANYL)PYRIDINE 3,5 DICARBONITRILE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 4 AMINOPYRIDINE; 6 [(4 NITROBENZYL)THIO] 9 BETA DEXTRO RIBOFURANOSYLPURINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; APAMIN; ATROPINE; CHARYBDOTOXIN; DIPYRIDAMOLE; GLIBENCLAMIDE; IBERIOTOXIN; LUF 5835; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; PURINERGIC RECEPTOR; TETRODOTOXIN; TETRYLAMMONIUM; TETRYLAMMONIUM CHLORIDE; THEOPHYLLINE; UNCLASSIFIED DRUG; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ILEUM; IN VITRO STUDY; MALE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; INNERVATION; MUSCLE CONTRACTION; NERVE TRACT; PHYSIOLOGY;

ADENOSINE; ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ILEUM; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEURAL PATHWAYS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A3; RECEPTORS, ADENOSINE A2; RECEPTORS, PURINERGIC P1;

EID: 66149099615     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.03.006     Document Type: Article

References (32)

1. Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M., Del Tacca M., and Blandizzi C. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacology & Therapeutics 120 (2008) 233-253
2. Bailey S.J., and Hourani S.M. Effects of purines on the longitudinal muscle of the rat colon. British Journal of Pharmacology 105 (1992) 885-892
3. Boddy G., Bong A., Cho W., and Daniel E.E. ICC pacing mechanisms in intact mouse intestine differ from those in cultured or dissected intestine. American Journal of Physiology 286 (2004) G653-G662
4. Burnstock G. Purine and pyrimidine receptors. Cellular and Molecular Life Sciences 64 (2007) 1471-1483
5. Christofi F.L., Zhang H., Yu J.G., Guzman J., Xue J., Kim M., Wang Y.Z., and Cooke H.J. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. The Journal of Comparative Neurology 439 (2001) 46-64
6. Collis M.G., and Hourani S.M. Adenosine receptor subtypes. Trends in Pharmacological Sciences 14 (1993) 360-366
7. Dart C., and Standen N.B. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. Journal of Physiology 471 (1993) 767-786
8. De Backer O., and Lefebvre R.A. Mechanisms of relaxation by carbon monoxide-releasing molecule-2 in murine gastric fundus and jejunum. European Journal of Pharmacology 572 (31-10-2007) 197-206
9. De Man J.G., De Winter B.Y., Seerden T.C., De Schepper H.U., Herman A.G., and Pelckmans P.A. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved. British Journal of Pharmacology 140 (2003) 1108-1116
10. De Man J.G., Seerden T.C., De Winter B.Y., Van Marck E.A., Herman A.G., and Pelckmans P.A. Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. British Journal of Pharmacology 139 (2003) 172-184
11. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J., Richardson P.J., and Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. British Journal of Pharmacology 118 (1996) 1461-1468
12. Doughty J.M., Plane F., and Langton P.D. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. American Journal of Physiology 276 (1999) H1107-H1112
13. Gessi S., Merighi S., Varani K., Leung E., Mac L.S., and Borea P.A. The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacology & Therapeutics 117 (2008) 123-140
14. Kadowaki M., Takeda M., Tokita K., Hanaoka K., and Tomoi M. Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon. British Journal of Pharmacology 129 (2000) 871-876
15. Lee J.J., Talubmook C., and Parsons M.E. Activation of presynaptic A1-receptors by endogenous adenosine inhibits acetylcholine release in the guinea-pig ileum. Journal of Autonomic Pharmacology 21 (2001) 29-38
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
17. Moneta N.A., McDonald T.J., and Cook M.A. Endogenous adenosine inhibits evoked substance P release from perifused networks of myenteric ganglia. American Journal of Physiology 272 (1997) G38-G45
18. + channel activation. American Journal of Physiology 265 (1993) H1289-H1293
19. Nicholls J., and Hourani S.M. Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae. European Journal of Pharmacology 338 (5-11-1997) 143-150
20. Nicholls J., Hourani S.M., and Kitchen I. Characterization of P1-purinoceptors on rat duodenum and urinary bladder. British Journal of Pharmacology 105 (1992) 639-642
21. Nicholls J., Brownhill V.R., and Hourani S.M. Characterization of P1-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae. British Journal of Pharmacology 117 (1996) 170-174
22. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews 50 (1998) 413-492
23. Serio R., Mule F., Adamo E.B., and Postorino A. Evidence against purines being neurotransmitters of non-adrenergic, non-cholinergic nerves in rat duodenum. European Journal of Pharmacology 182 (1990) 487-495
24. Serio R., Alessandro M., Zizzo M.G., Tamburello M.P., and Mule F. Neurotransmitters involved in the fast inhibitory junction potentials in mouse distal colon. European Journal of Pharmacology 460 (2003) 183-190
25. Storr M., Thammer J., Dunkel R., Schusdziarra V., and Allescher H.D. Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum. BMC Neuroscience 3 (2002) 21-20-12-
26. Tomaru A., Ina Y., Kishibayashi N., and Karasawa A. Excitation and inhibition via adenosine receptors of the twitch response to electrical stimulation in isolated guinea pig ileum. Japanese Journal of Pharmacology 69 (1995) 429-433
27. Woods C.M., Toouli J., and Saccone G.T. A2A and A3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro. British Journal of Pharmacology 138 (2003) 1333-1339
28. Yang S.J., An J.Y., Shim J.O., Park C.H., Huh I.H., and Sohn U.D. The mechanism of contraction by 2-chloroadenosine in cat detrusor muscle cells. The Journal of Urolology 163 (2000) 652-658
29. Zizzo M.G., Mule F., and Serio R. Inhibitory responses to exogenous adenosine in murine proximal and distal colon. British Journal of Pharmacology 148 (2006) 956-963
30. Zizzo M.G., Mule F., and Serio R. Mechanisms underlying the nitric oxide inhibitory effects in mouse ileal longitudinal muscle. Canadian Journal of Physiology and Pharmacology 83 (2005) 805-810
31. Zizzo M.G., Mule F., and Serio R. Mechanisms underlying the inhibitory effects induced by pituitary adenylate cyclase-activating peptide in mouse ileum. European Journal of Pharmacology 521 (2005) 133-138
32. Zygmunt P.M., Edwards G., Weston A.H., Larsson B., and Hogestatt E.D. Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. British Journal of Pharmacology 121 (1997) 141-149